Tag: Lexicon Pharmaceuticals

RELIEF-DPN-1 clinical trial : Lexicon begins patient dosing with LX9211

pharmanewsdaily- September 6, 2020

RELIEF-DPN-1 clinical trial : Lexicon Pharmaceuticals has started patient dosing in a phase 2 trial of LX9211 for the treatment of diabetic peripheral neuropathic pain. ... Read More

Lexicon’s Xermelo gets FDA approval to treat carcinoid syndrome diarrhea

pharmanewsdaily- March 1, 2017

Lexicon Pharmaceuticals’ oral drug Xermelo (telotristat ethyl) 250mg has been approved in combination with somatostatin analog (SSA) therapy by the US Food and Drug Administration ... Read More